Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Stem Cells and Development|October 1, 2009
Functional differences between mesenchymal stem cell populations are reflected by their transcriptomeBastiaan J H Jansen, Christian Gilissen, Helene Roelofs, et al.
British Journal of Haematology|August 30, 2002
Abnormal WT1 expression in the CD34-negative compartment in myelodysplastic bone marrowJeroen P Van Dijk, Gertrudis H J N Knops, Louis T F Van De Locht, et al.
Plos Pathogens|March 14, 2009
The tetraspanin protein CD37 regulates IgA responses and anti-fungal immunityAnnemiek B van Spriel, Mariam Sofi, Kate H Gartlan, et al.
Leukemia Research|May 19, 2005
Impaired breast cancer resistance protein mediated drug transport in plasma cells in multiple myelomaMarc H G P Raaijmakers, Elke P L M de Grouw, Leonie H H Heuver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemiaMarc H G P Raaijmakers, Elke P L M de Grouw, Leonie H H Heuver, et al.
British Journal of Haematology|April 16, 2008
Expression of P2X5 in lymphoid malignancies results in LRH-1-specific cytotoxic T-cell-mediated lysisIngrid M Overes, Björn de Rijke, Agnes van Horssen-Zoetbrood, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 8, 2010
Analysis of efficacy and prognostic factors of lenalidomide treatment as part of a Dutch compassionate use programEvelien Kneppers, Henk M Lokhorst, Corien M Eeltink, et al.
The Lancet. Haematology|March 24, 2017
Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysisRick Admiraal, Stefan Nierkens, Moniek A de Witte, et al.
Blood Advances|February 11, 2021
αβ T-cell graft depletion for allogeneic HSCT in adults with hematological malignanciesMoniek A de Witte, Anke Janssen, Klaartje Nijssen, et al.
Haematologica|February 10, 2015
Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology OncologyBouke P C Hazenberg, Alexandra Croockewit, Bronno van der Holt, et al.
Pageof 4